On (b)(6) 2014, an instrumentation laboratory representative became aware of an incident that occurred at (b)(6) on (b)(6) 2014.The customer indicated that their acl top 500 cts reported 17 erroneous aptt results using hemosil synthasil.Per their description of the event, the first patient sample contained a clot and they believe that it contaminated the instrument, causing the erroneous 17 test results.Of the affected patient samples, 4 of 17 were heparinized patients.As a result, 3 of the 4 patients had their heparin dosage changed based on the incorrect aptt results.All were subsequently corrected when the samples were repeated and corrected results obtained.There were no associated adverse events with this sample handling issue.
|
The site has instituted some safeguards in their laboratory that include repeating any aptt value of <20 seconds on a second analyzer, and including delta checks in their lis system to flag results that are noted to be beyond the normal variation of sample to sample differences.This issue appears to have been well characterized by the site and appropriate action has been taken to recognize aberrant values and assess the need to retest.There was no indication of an instrument or reagent malfunction.Therefore, no remedial action is required by instrumentation laboratory co.
|